SKU:  PME100071     Target:  CEACAM5

Price: 10μg $82.00; 50μg $320.00 ; 100 μg $480.00

SKU:  PME-M100060     Target:  CEACAM5

Price: 10μg $120.00 ; 50μg $450.00 ; 100 μg $660.00

SKU:  PME101570     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101573     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101572     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101571     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101574     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101575     Target:  CEACAM5

Price: 10μg $125.00 ; 50μg $469.00 ; 100 μg $688.00

SKU:  PME101497     Target:  CEACAM5

Price:10μg $87.00 ; 50μg $318.00 ; 100μg $478.00

SKU:  PME101496     Target:  CEACAM5

Price:10μg $87.00 ; 50μg $318.00 ; 100μg $478.00

SKU:  PME-C100033     Target:  CEACAM5

Price:10μg $120.00; 50μg $380.00; 100μg $570.00


Posts found

CEACAM5, an emerging target for cancer therapy

Human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), initially discovered in colon cancer by Gold [...]

Emerging Trends: ADC Drug Targets to Watch at ASCO 2024

The 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) will take place in [...]

Navigating the ADC Frontier: Unleashing the Magic of Antibody-Drug Conjugates

Antibody-drug conjugates (ADCs) have been one of the hottest areas in the biopharmaceutical industry in [...]

Unraveling the Mystery of ‘Million-Dollar’ CAR-T Therapy

In 2012, a young girl named Emily Whitehead, suffering from acute lymphoblastic leukemia, became the [...]

Unlocking the Potential of Mammalian Cell Display in Antibody Drug Innovation

In 1986, the world’s first monoclonal therapeutic drug, Orthoclone (OKT3), was approved by the FDA [...]


Pages found